The Board granted an initial rating of 60 percent for interstitial pulmonary fibrosis, effective August 10, 2022.
The deciding factor: The evidence supported a finding that the Veteran's interstitial pulmonary fibrosis manifested in a DLCO (SB) of 40 to 55 percent predicted during the relevant period, warranting a 60 percent rating.
- Claimed conditions
- Interstitial pulmonary fibrosis
- How they argued it
- Reopened with new and material evidence
- Exposure basis
- None
- Rating assigned
- 60%
- Decision date
- July 1, 2025
- Citation
- A25056588
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board granted an effective date of February 12, 2019, for the grant of service connection for interstitial pulmonary fibrosis based on a liberalizing law.
- Partly granted
The Board granted a 30 percent rating for benign paroxysmal positional vertigo (BPPV) prior to June 12, 2024, and denied all other claims including service connection for various respiratory conditions.
- Denied
The Board denied an initial compensable rating for interstitial pulmonary fibrosis as the Veteran's condition did not meet the criteria for a compensable evaluation.
- Remanded (sent back)
The Board remands the claim for service connection for sarcoidosis as new and relevant evidence has been received since the previous denial.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.